Is Tempus AI Inc (TEM) a risky stock?
As of July 27, 2026, Clavix grades Tempus AI Inc (TEM) D for risk, a composite score of 40 out of 100 on an A+ to F scale, which puts TEM in the "elevated risk" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 27, 2026. Clavix regrades every trading day.
TEM price, last 3 months
TEM's daily closes over the past three months. Clavix reads risk from the fundamentals and news behind the price, not the line itself.
The five risk dimensions behind TEM's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how TEM scores on each, as of July 27, 2026.
What's moving TEM's risk right now
Company-specific signals Clavix flags behind TEM's current grade, drawn from recent news and filings as of July 27, 2026.
The purchase signals institutional confidence in Tempus AI's long-term growth prospects despite recent volatility, potentially providing support for the stock price and validating…
The deal strengthens Tempus's competitive moat in oncology diagnostics by vertically integrating MRD into its existing tumor profiling and biopharma channels, likely accelerating…
The acquisition gives TEM vertical control over a key cancer test, potentially improving margins and competitive positioning in the oncology diagnostics market, though the $1.5B p…
Recent TEM news
The latest headlines Clavix ingested for Tempus AI Inc, newest first. These feed the news-sentiment dimension of TEM's grade.
-
Tempus AI (TEM) has made a $1.5 billion bet on liquid biopsy cancer recurrence surveillance, highlighted through a family narrative where an oncologist recommends a new blood-based monitoring test over traditional imaging. The article frames TEM's strategy around combining forces with another testing company to offer highly sensitive recurrence detection.
What a D grade means
On the Clavix A+ to F scale, TEM's composite of 40 falls in the D band (35–49), read as "elevated risk." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell TEM or any security. Grades are risk indicators, not predictions of return. Data may be delayed.